Sign Out
Pregnancy: There are no clinical data from the use of OLIMEL N12E in pregnant women. No animal reproductive studies have been performed with OLIMEL N12E (see Pharmacology: Toxicology: Preclinical safety data under Actions). Taking into account the use and indications of OLIMEL N12E, the product may be considered during pregnancy, if necessary. OLIMEL N12E should only be given to pregnant women after careful consideration.
Breast-feeding: There is insufficient information on the excretion of OLIMEL N12E components/metabolites in human milk. Parenteral nutrition may become necessary during breast-feeding. OLIMEL N12E should only be given to breast-feeding women after careful consideration.
Fertility: No adequate data are available.
